ME00547B - Upotreba inhibitora il-18 kod poremećaja hipersenzitinosti (preosjetljivosti) - Google Patents

Upotreba inhibitora il-18 kod poremećaja hipersenzitinosti (preosjetljivosti)

Info

Publication number
ME00547B
ME00547B MEP-2008-641A MEP64108A ME00547B ME 00547 B ME00547 B ME 00547B ME P64108 A MEP64108 A ME P64108A ME 00547 B ME00547 B ME 00547B
Authority
ME
Montenegro
Prior art keywords
inhibitors
hypersensitivity disorders
hypersensitivity
disorders
medicaments
Prior art date
Application number
MEP-2008-641A
Other languages
English (en)
Inventor
Vilbois Marie Kosco
Yolande Chvatchko
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Publication of ME00547B publication Critical patent/ME00547B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Ovaj pronalazak se odnosi na upotrebu inhibitora IL-18 u preparatimamedikamenata za tretman i/ili prevenciju poremećaja preosetljivosti, a posebno odloženog tipa preosetljivosti.
MEP-2008-641A 2001-08-10 2002-08-01 Upotreba inhibitora il-18 kod poremećaja hipersenzitinosti (preosjetljivosti) ME00547B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01118811 2001-08-10
EP02100735 2002-06-20
PCT/EP2002/008591 WO2003013577A2 (en) 2001-08-10 2002-08-01 Use of il-18 inhibitors in hypersensitivity disorders

Publications (1)

Publication Number Publication Date
ME00547B true ME00547B (me) 2011-12-20

Family

ID=26076673

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2008-641A ME00547B (me) 2001-08-10 2002-08-01 Upotreba inhibitora il-18 kod poremećaja hipersenzitinosti (preosjetljivosti)

Country Status (27)

Country Link
US (1) US20040247598A1 (me)
EP (1) EP1423138B1 (me)
JP (1) JP4301942B2 (me)
KR (1) KR20040030948A (me)
CN (1) CN100500210C (me)
AR (1) AR035274A1 (me)
AU (1) AU2002331376B2 (me)
BR (1) BRPI0211827B8 (me)
CA (1) CA2456247C (me)
CY (1) CY1116137T1 (me)
DK (1) DK1423138T3 (me)
EA (1) EA006745B1 (me)
ES (1) ES2533253T3 (me)
HK (1) HK1069780A1 (me)
HR (1) HRP20040071B1 (me)
HU (1) HU230377B1 (me)
IL (2) IL160230A0 (me)
ME (1) ME00547B (me)
MX (1) MXPA04001230A (me)
NO (1) NO335688B1 (me)
PL (1) PL227130B1 (me)
PT (1) PT1423138E (me)
RS (1) RS52224B (me)
SI (1) SI1423138T1 (me)
UA (1) UA78516C2 (me)
WO (1) WO2003013577A2 (me)
ZA (1) ZA200400442B (me)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2177907B1 (en) * 2004-06-30 2014-01-01 Atsuo Sekiyama Indicator agent for noninflammatory stress response and use therefor
DK2267024T3 (da) 2005-06-03 2012-06-25 Ares Trading Sa Fremstilling af rekombinant II-18 bindingsprotein
SI1891088T1 (sl) 2005-06-10 2012-02-29 Ares Trading Sa Postopek za äśiĺ äśenje il-18 vezavnega proteina
EA017303B1 (ru) 2006-05-25 2012-11-30 Глаксо Груп Лимитед Модифицированные гуманизированные антитела против интерлейкина-18 и их применение
CN103458904B (zh) * 2010-12-16 2016-09-28 株式会社明治 格氏乳杆菌的菌体级分在制造用于减轻迟发型变态反应的组合物中的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US6087116A (en) * 1997-03-12 2000-07-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18 (IL-18) receptor polypeptides and their uses
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
EP1062210B1 (en) * 1998-03-09 2005-06-01 Vertex Pharmaceuticals Incorporated 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
CA2276216A1 (en) * 1998-06-24 1999-12-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo An artificial peptide capable of neutralizing the biological activity of interleukin-18
WO2000012555A1 (fr) * 1998-09-01 2000-03-09 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Proteine de liaison de l'interleukine 18
AU5282600A (en) * 1999-05-20 2000-12-12 Hyseq, Inc. Interleukin-1 hy2 materials and methods
WO2002032374A2 (en) * 2000-10-18 2002-04-25 Immunex Corporation Methods for treating il-18 mediated disorders

Also Published As

Publication number Publication date
WO2003013577A2 (en) 2003-02-20
AR035274A1 (es) 2004-05-05
IL160230A0 (en) 2004-07-25
CA2456247C (en) 2013-09-10
IL160230A (en) 2014-11-30
HRP20040071B1 (hr) 2015-08-28
WO2003013577A3 (en) 2003-09-25
BR0211827A (pt) 2004-08-31
EP1423138A2 (en) 2004-06-02
AU2002331376B2 (en) 2007-06-14
BRPI0211827B1 (pt) 2019-07-23
ES2533253T3 (es) 2015-04-08
BRPI0211827B8 (pt) 2021-05-25
CA2456247A1 (en) 2003-02-20
CN1568193A (zh) 2005-01-19
HK1069780A1 (en) 2005-06-03
NO335688B1 (no) 2015-01-19
SI1423138T1 (sl) 2015-04-30
PL227130B1 (pl) 2017-10-31
PT1423138E (pt) 2015-02-09
HRP20040071A2 (en) 2004-10-31
HUP0401323A3 (en) 2006-01-30
JP4301942B2 (ja) 2009-07-22
KR20040030948A (ko) 2004-04-09
MXPA04001230A (es) 2004-05-27
EA006745B1 (ru) 2006-04-28
DK1423138T3 (en) 2015-02-23
HUP0401323A2 (hu) 2004-10-28
NO20040370L (no) 2004-03-23
CY1116137T1 (el) 2017-02-08
YU11904A (sh) 2006-08-17
UA78516C2 (en) 2007-04-10
HU230377B1 (hu) 2016-03-29
JP2005501080A (ja) 2005-01-13
ZA200400442B (en) 2005-03-30
EA200400296A1 (ru) 2004-06-24
CN100500210C (zh) 2009-06-17
EP1423138B1 (en) 2014-12-24
RS52224B (sr) 2012-10-31
PL368231A1 (en) 2005-03-21
US20040247598A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
ATE508735T1 (de) Pulmonale verabreichung von aminoglykosiden
SE9703693D0 (sv) Novel combination
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
PL378107A1 (pl) 1,2,4-triazyny hamujące HIV
HUP0400202A3 (en) Imidazolidindion derivatives having metalloproteinase inhibitor effect, their use and pharmaceutical compositions containing them
SE9802333D0 (sv) Novel combination
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
IL172773A0 (en) Formulations for the treatment of arhritis conditions
AU2002258066A1 (en) Dermatological and cosmetic compositions
ME00554B (me) KORIŠĆENJE IL-18 INHIBITORA ZA LIJEČENJE l/ILI PREVENCIJU ATEROSKLEROZE
ME00671B (me) Nova farmaceutska smeša
TW200510416A (en) P38 inhibitors and methods of use thereof
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
IL158559A (en) Use of 5-lipoxygenase inhibitors for the preparation of a pharmaceutical composition for treating acne
WO2003084539A3 (en) New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
ME00548B (me) Korišćenje inhibitora il-18 za liječenje i/ili prevenciju perifernih vaskularnih bolesti
TR200502508T2 (tr) IL-18 İnhibitörlerinin kullanımı.
WO2004085682A3 (de) Caspase inhibitoren, insbesondere von caspase-3, zur behandlung von influenza
HRP20050579B1 (hr) Nove sinergistiäśne kombinacije koje sadrže roflumilast i formoterol
ME00549B (me) Upotreba inhibitora il-18 za liječenje i/ili prevenciju srčanih oboljenja
AU2002346594A1 (en) Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation
ME00547B (me) Upotreba inhibitora il-18 kod poremećaja hipersenzitinosti (preosjetljivosti)
DK1196174T3 (da) Diætmæssigt calcium, som et tilskud til D-vitamin-forbindelsesbehandling af multipel sclerose
HUP0401633A2 (hu) Irbesartan alkalmazása pulmonális magas vérnyomás megelőzésére vagy kezelésére alkalmas gyógyszerkészítmény előállítására
ME00550B (me) Korišćenje il-18 inhibitora za lećenje ili prevenciju povreda cns